Advertisement Press Releases Archive - Page 105 of 231 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • MEGGLE now EXCiPACT™ Certified

    MEGGLE Group Wasserburg was granted an EXCiPACT™ certificate. Auditors from the certifying body SGS (Société Générale de Surveillance, Hamburg, Germany) confirmed in August, 2014 that the MEGGLE Business Group Excipients & Technology complies with the quality standards of Good Manufacturing & Good Distribution Practices (GMP & GDP) for its pharmaceutical excipients.

  • MEGGLE Starts Production in the USA

    MEGGLE Business Group Excipients & Technology, one of the world’s leading manufacturers of excipients for the pharmaceuticals industry, will start operating its first US production site in Le Sueur/Minnesota in September 2011. This will eliminate many bureaucratic and customs obstacles for US buyers and strongly accelerate transactions.

  • New Tablettose® Production Facility at MEGGLE

    Meggle Tablettose® has earned a worldwide reputation as a universal genius among direct compression excipients. It unites the excellent flowability of a course-grained lactose with the superior compressibility of a fine-milled lactose. Its fast disintegration, pure-white appearance, and textured surface make Tablettose® one of the most versatile, economical excipients for tablet production.